相似文献
1
RENAL HYPERTENSION PRODUCED BY AN AMINO ACID.
J Exp Med. 1941 Aug 31;74(3):235-46. doi: 10.1084/jem.74.3.235.
2
On the mechanism of L-dopa-induced postural hypotension in the cat.
Br J Pharmacol. 1973 Mar;47(3):437-51. doi: 10.1111/j.1476-5381.1973.tb08175.x.
3
THE ETIOLOGY OF HYPERTENSION DUE TO COMPLETE RENAL ISCHEMIA.
J Exp Med. 1940 Nov 30;72(6):763-76. doi: 10.1084/jem.72.6.763.
4
gamma-Glutamyl dopa: a kidney-specific dopamine precursor.
J Pharmacol Exp Ther. 1978 Jul;206(1):227-32.
5
Hypertension in the systemic blood of animals with experimental renal hypertension.
J Exp Med. 1948 Oct 1;88(4):389-400. doi: 10.1084/jem.88.4.389.
6
Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
J Clin Invest. 1971 Jun;50(6):1322-8. doi: 10.1172/JCI106611.
7
Altered tonic L-3,4-dihydroxyphenylalanine systems in the nucleus tractus solitarii and the rostral ventrolateral medulla of spontaneously hypertensive rats.
Neuroscience. 1995 Jul;67(1):95-106. doi: 10.1016/0306-4522(94)00611-8.
8
Dopamine and L-dopa potentiation of pressor responses to norepinephrine in isolated perfused rat kidneys.
J Cardiovasc Pharmacol. 1986 May-Jun;8(3):554-8. doi: 10.1097/00005344-198605000-00018.
9
Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension.
Nephrol Dial Transplant. 2001;16 Suppl 1:53-9. doi: 10.1093/ndt/16.suppl_1.53.
10
Organ-specific overexpression of renal LAT2 and enhanced tubular L-DOPA uptake precede the onset of hypertension.
Hypertension. 2003 Oct;42(4):613-8. doi: 10.1161/01.HYP.0000091822.00166.B1. Epub 2003 Sep 15.
引用本文的文献
1
Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award.
Hypertension. 2020 Jun;75(6):1386-1396. doi: 10.1161/HYPERTENSIONAHA.120.13896. Epub 2020 Apr 27.
2
THE METABOLISM OF THE ISCHEMIC KIDNEY : I. THE RESPIRATION AND THE OXIDASE ACTIVITY OF THE ISCHEMIC KIDNEY.
J Exp Med. 1943 Jul 1;78(1):75-89. doi: 10.1084/jem.78.1.75.
3
[Coordinated role of nerves, hormones and electrolytes in the pathophysiology of the blood pressure].
Acta Neuroveg (Wien). 1953;6(1-2):52-79. doi: 10.1007/BF01226664.
本文引用的文献
1
THE EFFECT OF TYROSINASE ON EXPERIMENTAL HYPERTENSION.
J Exp Med. 1941 Mar 31;73(4):531-50. doi: 10.1084/jem.73.4.531.
2
THE ROLE OF RENAL METABOLISM IN HYPERTENSION AND UREMIA.
J Exp Med. 1941 Feb 28;73(3):357-64. doi: 10.1084/jem.73.3.357.
3
THE ETIOLOGY OF HYPERTENSION DUE TO COMPLETE RENAL ISCHEMIA.
J Exp Med. 1940 Nov 30;72(6):763-76. doi: 10.1084/jem.72.6.763.
4
THE BEHAVIOR OF RENAL BLOOD FLOW AFTER PARTIAL CONSTRICTION OF THE RENAL ARTERY.
J Exp Med. 1940 Nov 30;72(6):707-16. doi: 10.1084/jem.72.6.707.
5
STUDIES ON THE RENAL ARTERIAL BLOOD PRESSURE AND THE METABOLISM OF KIDNEY TISSUE IN EXPERIMENTAL HYPERTENSION.
J Exp Med. 1940 Aug 31;72(3):289-99. doi: 10.1084/jem.72.3.289.
6
THE LIBERATION OF RENIN BY PERFUSION OF KIDNEYS FOLLOWING REDUCTION OF PULSE PRESSURE.
J Exp Med. 1940 Jul 31;72(2):201-16. doi: 10.1084/jem.72.2.201.
7
STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.
J Exp Med. 1934 Feb 28;59(3):347-79. doi: 10.1084/jem.59.3.347.
Zotero 插件